Compliance DeepDive
Is “vibe coding” a risk your pharma enterprise can afford? In this episode, we uncover why intuitive, undocumented development endangers patient safety and data integrity. Learn how FDA 21 CFR Part 11 and GxP demand rigorous validation, documentation, and change control—and why speed without structure is a recipe for failure. Context demands discipline. Tune in to Compliance Deepdive and discover how to code safely in regulated environments.
34 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Compliance DeepDive community!